Amgen (AMGN) stock forecast for 2023. Forecast tables and graphs.

Amgen (AMGN) stock forecast for 2023

Last update: September 27, 2023 (09:25)

Sector: Healthcare

The share price of Amgen Inc. (AMGN) now

What analysts predict: $263.68
52-week High/Low: $287.01 / $210.01

50/200 Day Moving Average: $252.45 / $244.15

This figure corresponds to the Average Price over the previous 50/200 days. For Amgen stocks, the 50-day moving average is the resistance level today.

For Amgen stocks, the 200-day moving average is the resistance level today.

Are you interested in Amgen stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Amgen stock price in 2023. How much will one Amgen share be worth in 2023? Is it worth taking profit / loss on Amgen stock now or waiting? What are analysts' forecasts for Amgen stock?

We forecast Amgen stock performance using neural networks based on historical data on Amgen stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. The Amgen stock prediction results are shown below and presented as a graph, table and text information.

Amgen stock forecasts are adjusted once a day based on the closing price of the previous trading day.

The minimum target price for Amgen analysts is $263.68.

Today 200 Day Moving Average is the support level (244.15 $).

50 Day Moving Average is the support level (252.45 $).

Historical and forecast chart of Amgen stock

The chart below shows the historical price of Amgen stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Amgen stock price can be found in the table below.

Amgen (AMGN) Forecast for 2023

Month Target Pes. Opt. Vol., %
Oct 262.91 250.60 283.10 11.48 %
Nov 264.80 242.87 275.92 11.98 %
Dec 270.52 253.31 283.50 10.65 %

Amgen information and performance

AMGen is an American biopharmaceutical company and the largest transnational independent biotechnology firm in the world. AMGen is engaged in research in the field of biology, opening up opportunities for patients with serious diseases such as cancer, bone damage, various kidney diseases, autoimmune diseases (in particular rheumatoid arthritis) and other diseases. The company uses progressive methods of gene engineering, which makes it possible to identify the complex pathogenesis of diseases, to comprehend the basics of human biology.

AMGen was founded in 1980, co-founder George B. Ratmann became the first CEO of the company, after several changes of leadership in May 2012, Robert A. Bradway, who has a bachelor’s degree in biology and a master’s degree from Harvard University, took the position. The company has had at least five major corporate acquisitions.

Official site of the company

Amgen Address


Market Capitalization: 143 909 765 000 $

Market capitalization of the Amgen Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of AMGN shares in the company outstanding by the market price of one share.

EBITDA: 13 763 000 000 $

EBITDA of Amgen is earnings before interest, income tax and depreciation of assets.

PE Ratio: 18.13

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: 1.55

Price/earnings to growth

DPS: 8.14

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: 0.0319

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: 14.84

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: 0.049
Quarterly Revenue Growth YOY: 0.059
Trailing PE: 18.13

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: 14.95

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 6.53

Enterprise Value (EV) /Revenue

EV To EBITDA: 13.85

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 534901000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A

Amgen price target for 2023 by month

Target values for the price of one Amgen share for Oct 2023.

The weighted average target price per Amgen share in Oct 2023 is: 262.91.
In Oct, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 11.478% volatility is expected.
Pessimistic target level: 250.60
Optimistic target level: 283.10

Target values for the price of one Amgen share for Nov 2023.

The weighted average target price per Amgen share in Nov 2023 is: 264.80.
In Nov, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 11.977% volatility is expected.
Pessimistic target level: 242.87
Optimistic target level: 275.92

Target values for the price of one Amgen share for Dec 2023.

The weighted average target price per Amgen share in Dec 2023 is: 270.52.
In Dec, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 10.649% volatility is expected.
Pessimistic target level: 253.31
Optimistic target level: 283.50

Amgen (AMGN) stock dividend

Amgen last paid dividends on 08/17/2023. The next scheduled payment will be on 09/08/2023. The amount of dividends is $8.14 per share. If the date of the next dividend payment has not been updated, it means that the issuer has not yet announced the exact payment. As soon as information becomes available, we will immediately update the data. Bookmark our portal to stay updated.

Last Split Factor:

Last Split Date: 01/01/1970

Splitting of shares is an increase in the number of securities of the issuing company circulating on the market due to a decrease in their value at constant capitalization.

For example, a 5: 1 ratio means that the value of one share will decrease 5 times, the total amount will increase 5 times. It is important to understand that this procedure does not change the capitalization of the company, as well as the total value of assets held in private hands.

Related stocks from Healthcare sector


All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.